# Association Between Human Milk-Targeted Metabolites and Maternal Characteristics: Targeted Metabolomic Profiling of Human Milk in Low-Income Settings

**Authors:** Sadia Parkar, Nadia Mazhar, Sumera Sharafat, Hamna Ganny, Gul Afshan, Samreen Memon, Khalid Wahab, Aneeta Hotwani, Daniela Hampel, Sidra Kaleem Jafri

PMC · DOI: 10.3390/metabo16030162 · Metabolites · 2026-02-28

## TL;DR

This study explores how human milk metabolites vary with maternal and infant characteristics in low-income settings, revealing connections between milk composition and factors like maternal age and child age.

## Contribution

The study provides novel insights into the HM metabolome's association with maternal and infant characteristics in low-income populations.

## Key findings

- Maternal age correlates with metabolites like cholesteryl esters and sphingomyelins.
- Child age is linked to metabolites in acylcarnitine and phosphatidylcholine classes.
- Child gender is associated with ceramides and phosphatidylcholines.

## Abstract

Background/Objectives: Human milk (HM) is recognized as the optimal source of infant nutrition, particularly during the first six months of life. While its nutritional aspects and bioactive components are well studied, the HM metabolome remains less understood, particularly in low- and middle-income countries. This study utilized targeted metabolomics for HM profiling and investigated associations of the HM metabolome with maternal and infant characteristics. Methods: In total, 267 HM samples and demographic data from mothers participating in the Maternal and environmental Impact assessment on Neurodevelopment in Early childhood years (MINE) study were collected during enrolment (up to 6-months postpartum) and analyzed using the MxP® Quant 500 targeted metabolomics kit from Biocrates. Results: A total of 440 metabolites were quantified, mostly lipids such as triglycerides (59.73%), phosphatidylcholines (14.25%), and diglycerides (8.49%), and small molecules including amino acids (26.67%), amino acid-related compounds (21.33%), hexosylceramides (17.33%), and fatty acids (14.67%). Maternal age was positively correlated with a wide range of metabolites, mainly cholesteryl esters, sphingomyelins, triglycerides, and acylcarnitines, while child age was associated with metabolites belonging to acylcarnitine, phosphatidyl-choline, ceramide, diacylglycerol, sphingomyelin, and triglyceride classes. Child’s gender was associated with metabolites, including ceramides, phosphatidylcholines, and sphingomyelins. Pathway enrichment analysis revealed that the metabolites were significantly enriched in valine, leucine, and isoleucine biosynthesis; arginine biosynthesis; phenylalanine, tyrosine, and tryptophan biosynthesis; and glutathione metabolism; however, these reflect annotation-based clustering rather than evidence of active metabolic processes in HM. Conclusions: The HM metabolome varies with maternal and infant characteristics, particularly infant age, reflecting cross-sectional differences in milk composition among mother–infant dyads. Enrichment of metabolites annotated to amino acid and antioxidant-related pathways highlights coordinated representation of nutritionally relevant compounds. These findings provide new insight into the factors shaping HM composition in a low- and middle-income populations.

## Full-text entities

- **Genes:** PC (pyruvate carboxylase) [NCBI Gene 5091] {aka PCB}
- **Diseases:** gastrointestinal malformations (MESH:D005767), diabetes mellitus (MESH:D003920), injury to (MESH:D014947), Maternal (MESH:D000079262), obesity (MESH:D009765), HM (MESH:D016269), ventricle enlargement (MESH:D006332), preterm birth (MESH:D047928), hypertension (MESH:D006973), hypoxic (MESH:D002534), congenital anomalies (MESH:D000013), ischemic (MESH:D002545), pre-eclampsia (MESH:D011225), fetal abnormalities (MESH:D005315)
- **Chemicals:** 3-methylhistidine (MESH:C028118), sphingomyelin (MESH:D013109), arginine (MESH:D001120), DHA (MESH:C027493), sarcosine (MESH:D012521), hexose (MESH:D006601), aconitic acid (MESH:D000156), tryptophan (MESH:D014364), spermidine (MESH:D013095), hippuric acid (MESH:C030514), hypotaurine (MESH:C003949), Lipid (MESH:D008055), fat (MESH:D005223), glycodeoxycholic acid (MESH:D006002), Triglyceride (MESH:D014280), serine (MESH:D012694), phenylalanine (MESH:D010649), PC (MESH:C053518), GABA (MESH:D005680), C4 (MESH:C058899), C3, and C4 (-), SM (MESH:D012493), dihexosyl-ceramides (MESH:C012905), carboxylic acid (MESH:D002264), MUFA (MESH:D005229), TG (MESH:D013866), Ala (MESH:D000409), calcium (MESH:D002118), polyamines (MESH:D011073), BCAAs (MESH:D000597), C2 (MESH:C023714), threonine (MESH:D013912), indoxyl sulfate (MESH:D007200), O (MESH:D010100), methionine (MESH:D008715), Fatty acids (MESH:D005227), beta-alanine (MESH:D015091), Acylcarnitine (MESH:C116917), Carbohydrates (MESH:D002241), His (MESH:D006639), cresols (MESH:D003408), taurine (MESH:D013654), spermine (MESH:D013096), amines (MESH:D000588), putrescine (MESH:D011700), alkaloids (MESH:D000470), choline (MESH:D002794), porphyrin (MESH:D011166), oleic acid (MESH:D019301), nicotinate (MESH:D009525), biogenic amines (MESH:D001679), aspartate (MESH:D001224), CE (MESH:D002563), nicotinamide (MESH:D009536), glucose (MESH:D005947), proline (MESH:D011392), tyrosine (MESH:D014443), 1-methylhistidine (MESH:C028120), phosphorus (MESH:D010758), glycerophospholipid (MESH:D020404)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13028068/full.md

## Figures

17 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13028068/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC13028068/full.md

---
Source: https://tomesphere.com/paper/PMC13028068